This new ingredient is called Bacillus subtilis DE111 HS (highly soluble), developed to fill in increasing consumer demand for dietary supplement delivery methods other that pills or capsules.
“DE111’s high tolerance of heat and pH extremes has made it a great strain for natural products manufacturers. But we needed to improve its suitability for tricky delivery systems requiring solubility,” said Deerland Enzymes & Probiotics vice president of science and technology, Dr. John Deaton.
“With DE111-HS, we’ve cleared this hurdle. It mixes easily with liquid and still maintains a high count of colony forming units (CFUs) in the finished product.”
According to the company, B. subtilis DE111 differs from most probiotic strains in its ability to produce protective spores. These spores can survive stomach acid and then ‘activate’ under ideal conditions like those inside the human gut.
“An added benefit, DE111’s optimal growth temperature is 37°C, that of the human body, unlike other spore strains which grow better at lower temperatures,” the company explained in a press release.
Deerland Enzymes & Probiotics vice president of sales, Tod Burgess, said: “There is a booming interest in probiotics, and consumers want easier ways to nurture their health with these microbes—through what they eat and drink. With the help of DE111-HS, our customers have seen tremendous success in meeting this demand. They’re using it in innovative food and beverage products with greater ease in manufacturing.”
Earlier this year, a study by the company was published in the Journal of Probiotics & Health, which suggested that the patented DE111 strain may help improve occasional constipation compared to placebo.